🇺🇸 HUTCHMED (China) LtdHCM
Get HUTCHMED (China) Ltd filings on Telegram the moment they are published.
Follow HUTCHMED (China) Ltd on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 6-K — Foreign issuer report
Overview: Announces positive Phase III SAFFRON and SANOVO trial results for ORPATHYS® plus TAGRISSO® in treating EGFR-mutated non-small cell lung cancer.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest